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SOUHRN
Úvod: Zdokonalení prevence a léčby ischemické choroby srdeční i zvýšení dostupnosti koronárních jednotek 
představují významná opatření pro snížení incidence akutních koronárních syndromů (AKS). Pro optimální 
algoritmus hospitalizace a léčby pacientů s AKS je naprosto nezbytné vytvoření systému akutní koronární péče.
Cíl: Cílem naší studie bylo stanovit roční incidenci AKS i kvalitu akutní koronární péče v Litvě.
Metody: Byly analyzovány údaje Litevského registru akutních koronárních syndromů za období 2005 až 2010.
Výsledky: Od roku 2005 se roční incidence hospitalizací pro AKS v Litvě statisticky významně snížila. Podle 
údajů registru klesla v daném šestiletém období roční incidence AKS bez elevací úseku ST (non-ST AKS) 
v absolutních číslech z 8 019 na 4 613. Bylo prokázáno důslednější uplatňování léčby podle doporučených 
postupů i časné invazivní strategie u pacientů s AKS. Zvýšily se počty primárních koronárních intervencí ze 
7,9 % v roce 2005 na 57,0 % v roce 2010; výsledkem bylo snížení podílu pacientů se STEMI, u nichž vůbec 
nebyla provedena reperfuzní léčba (ze 45 % v roce 2005 na 21 % v roce 2010).
Závěry: V období 2005 až 2010 došlo v Litvě k poklesu roční incidence hospitalizací pro AKS, zvláště non-STE 
AKS, i ke zlepšení léčby AKS podle doporučených postupů.
© 2014, ČKS. Published by Elsevier Urban and Partner Sp. z o.o. All rights reserved.
ABSTRACT 
Introduction: Improvement in coronary heart disease prevention and treatment, as well as availability of 
coronary care facilities, are important measures for reduction of acute coronary syndrome (ACS) incidence. 
Centralized acute coronary care system is crucial to provide optimal hospitalization and management algo-
rithm for ACS patients.
Aim: The aim of the current report was to assess annual incidence of ACS, and quality of acute coronary 
care in Latvia.
Methods: The data from The Latvian Registry of Acute Coronary Syndromes were analyzed covering the time 
period from year 2005 to year 2010.
Results: Since the year 2005 the annual incidence of hospitalization due to ACS decreased signifi cantly in 
Latvia. Annual incidence of non-ST-elevation ACS (NSTE-ACS) decreased from 8 019 to 4 613 in absolute 
numbers based on the registry data during six years. Improvement in use of guidelines based therapy and 
early invasive strategy in ACS patients was observed. Increase in primary percutaneous coronary intervention 
was achieved from 7.9% in year 2005 to 57.0% in year 2010 contributing to reduction in proportion of STEMI 
patients without any reperfusion (from 45% in year 2005 to 21% in year 2010).
Conclusions: Annual incidence of hospitalized ACS, especially NSTE-ACS decreased, and guidelines based 
management of ACS improved from 2005 to 2010 in Latvia.
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Introduction
Continuous physician education, development of clinical 
guidelines and recommendations, and its implementati-
on in practice, availability of diagnostic coronary angio-
graphy and coronary intervention are measures that are 
crucial in reduction of acute coronary syndrome (ACS) 
morbidity. Moreover, centralized emergency medical 
services (EMS) are vital in order to promote optimal al-
gorithm of hospitalization or the transfer to specialized 
hospitals to provide best possible care for patients with 
ACS. ACS registry, covering the whole country, represents 
both consequences of primary and secondary prevention 
by decreasing incidence of ACS as well as serves as a mea-
sure for quality of care in patients hospitalized with ACS.
The new member states of the European Union have 
high cardiovascular disease rates, which is in marked con-
trast to the most economically stable European countries 
where declines in cardiovascular mortality rates have 
been experienced over last 30 years [1]. Coronary heart 
disease is the leading cause of death in Latvia [2]. ACS is 
the most common reason for cardiac hospitalization tied 
with high mortality risk and requiring advanced care [3]. 
Early coronary angiography and revascularization 
is a cornerstone in contemporary management of ACS, 
however, improvement of regionalized systems is of no 
less importance [4–7]. In patients with ST-segment eleva-
tion myocardial infarction (STEMI) primary percutaneous 
coronary intervention (P-PCI) in a time saving manner is 
the preferred strategy. Thus empowering EMS and imple-
mentation of regional guidelines were the fi rst steps in 
forming an effective STEMI regional network providing 
majority of patients with P-PCI and others with fi brinoly-
sis (FL) and facilitated PCI. Additionally early invasive stra-
tegy in non-ST-elevation ACS (NSTE-ACS) patients reduces 
refractory ischemia and improves survival in intermediate 
and high risk NSTE-ACS patients [5,8–14].
Assessment of quality has become an integral part of 
care, usually by the evaluation of implementation of clini-
cal guidelines in real life practice. Thus, to analyze acute 
coronary care quality in Latvia, the ongoing national re-
gistry of ACS was introduced in the year 2005. The aim of 
this report was to analyze annual incidence of ACS and 
quality of care in ACS patients during the time period of 
5 years from 2005 to 2010 in Latvia.    
Methods
The Latvian Registry of Acute Coronary Syndromes is an 
ongoing, prospective, multi-center, observational registry 
designed to examine current epidemiology, in-hospital 
management and the outcome of patients with ACS in 
Latvia. A total of 34 hospitals participated in the registry 
during study period from 1st of January 2005 to 31st of De-
cember 2010. To minimize selection bias all consecutive pa-
tients with a suspected diagnosis of acute coronary syndro-
me were included, regardless of the treatment strategy, 
or outcome. Data concerning baseline demographic and 
clinical characteristics, relevant laboratory results, pharma-
cotherapy during hospital stay, and adverse cardiovascu-
lar outcomes were recorded on a standardized electronic 
Table 1 – Characteristics of NSTE-ACS patients.
2005 2006 2007 2008 2009 2010 p-value
Number of patients, n 8 019 6 437 5 573 6 184 4 437 4 613
Cardiogenic shock, n (%) 80 (1.0) 131 (2.0) 122 (2.2) 153 (2.5) 117 (2.6) 65 (1.4) < 0.0001
Intra-hospital death, n (%) 269 (3.4) 258 (4.0) 284 (5.1) 348 (5.6) 230 (5.2) 166 (3.6) < 0.0001
Age ± SD, years 68.32 ± 11.29 68.59 ± 11.26 68.67 ± 11.41 69.73 ± 11.40 69.25 ± 11.69 68.84 ± 11.61 < 0.0001
Arterial hypertension, n (%) 5 033 (62.8) 4 345 (67.5) 3 753 (67.3) 4 254 (68.8) 2 820 (63.6) 2 911 (63.1) < 0.0001
Diabetes mellitus, n (%) 1 424 (17.8) 1 145 (17.8) 1 001 (18.0) 1 136 (18.4) 807 (18.2) 918 (19.9) 0.051
Hypercholesterolemia 
(TC > 4.5 mmol/l), n (%)
3 905 (48.8) 2 845 (44.2) 2 927 (52.5) 3 243 (52.4) 2 247 (50.6) 2 094 (45.4) < 0.0001
Previous myocardial 
infarction, n (%) 3 170 (39.5) 2 404 (37.3) 2 079 (37.3) 2 304 (37.3) 1 604 (36.2) 1 562 (33.9) < 0.0001
Previous stroke, n (%) 519 (6.5) 415 (6.4) 363 (6.5) 407 (6.6) 275 (6.2) 269 (5.8) 0.651
Atrial fi brillation, n (%) 1 434 (17.9) 1 177 (18.3) 1 005 (18.0) 1 151 (18.6) 718 (16.2) 638 (13.8) < 0.0001
PCI at index hospitalization, n (%) 507 (6.3) 663 (10.3) 621 (11.1) 719 (11.6) 1 016 (22.9) 1 295 (28.1) < 0.0001
Coronary angiography at 
index hospitalization, n (%)
– – 859 (15.4) 1031 (16.7) 1391 (31.4) 1699 (36.8) < 0.0001
Aspirin, n (%) 7 250 (90.4) 5 817 (90.4) 5 004 (89.8) 5 583 (90.3) 3 988 (89.9) 4 056 (87.9) < 0.0001
Thienopyridines, n (%) 1 384 (17.3) 2 249 (34.9) 2 804 (50.3) 3 232 (52.3) 2 744 (61.8) 3 406 (73.8) < 0.0001
ACE-inhibitors, n (%) 5 802 (72.4) 4 877 (75.8) 4 031 (72.3) 4 473 (72.3) 3 060 (69.0) 3 027 (65.6) < 0.0001
Beta-blockers, n (%) 6 740 (84.1) 5 405 (84.0) 4 635 (83.2) 5 133 (83.0) 3 697 (83.3) 3 866 (83.8) 0.471
Statins, n (%) 5 316 (66.3) 5 069 (78.7) 4 557 (81.8) 5 052 (81.7) 3 781 (85.2) 3 941 (85.4) < 0.0001
GP IIb/IIIa inhibitors, n (%) 255 (3.2) 409 (6.4) 486 (8.7) 517 (8.4) 429 (9.7) 352 (7.6) < 0.0001
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web page based case report form. Data were collected 
in a central electronic database. Standardized defi nitions 
were used for adverse events and fi nal diagnosis [15,16]. 
For the purpose of the present analysis patients were clas-
sifi ed as NSTE-ACS and STEMI. The occurrence of other is-
chemic or bleeding events was not analyzed. We analyzed: 
adherence to therapies recommended by guidelines, early 
interventional strategy, coronary risk factors, patient his-
tory data and in-hospital mortality. Hypercholesterolemia 
was defi ned as total blood cholesterol above 4.5 mmol/l, 
and arterial hypertension was defi ned as blood pressure 
140/90 mmHg or above without medications or the use of 
antihypertensive agents in history.
Reperfusion strategy was documented in STEMI pa-
tients. STEMI patients eligible for reperfusion therapy 
were defi ned as patients hospitalized within 12 h from 
symptom onset. Reperfusion strategy, P-PCI or fi brinolysis 
(FT) was analyzed in this patient subgroup.
The data of Central Statistical Bureau Database of Latvia 
were used for the calculation of annual incidence of STEMI 
and NSTE-ACS per million population. This was calculated 
for each year using number of total population for each 
year given by Central Statistical Bureau Database of Latvia. 
Statistical analyses
Statistical analyses were performed with SPSS software (ver-
sion 17.0, Chicago, Illinois, USA). Continuous values are ex-
pressed as mean ± SD. Categorical variables are presented 
as percentages. Categorical variables were compared with 
Chi-square test and continuous variables with ANOVA. P va-
lues under 0.05 were considered as statistically signifi cant.
Results
Since the year 2005 the total number of ACS patients, 
both STEMI and NSTE-ACS, hospitalized across Latvia as 
assessed by current registry decreased (Tables 1 and 2). 
Number of STEMI and NSTE-ACS calculated per million 
population decreased over years (Fig. 1). More prominent 
decrease was observed among NSTE-ACS patients. To-
Table 2 – Characteristics of STEMI patients.
2005 2006 2007 2008 2009 2010 p-value
Number of patients, n 1 815 1 823 1 499 1 703 1 530 1 542
Cardiogenic shock, n (%) 156 (8.6) 198 (10.9) 123 (8.2) 158 (9.3) 198 (12.9) 157 (10.2) < 0.0001
Intra-hospital death, n (%) 312 (17.4) 288 (15.8) 208 (13.9) 270 (15.9) 219 (14.3) 206 (13.4) 0.01
Age ± SD, years 67.49 ± 12.07 66.85 ± 12.33 65.81 ± 12.48 67.16 ± 12.36 65.56 ± 13.15 65.90 ± 12.58 < 0.0001
Arterial hypertension, n (%) 872 (48.0) 981 (53.8) 755 (50.4) 898 (52.7) 733 (47.9) 712 (46.2) < 0.0001
Diabetes mellitus, n (%) 298 (16.4) 324 (17.8) 235 (15.7) 266 (15.6) 219 (14.3) 205 (13.3) 0.008
Hypercholesterolemia, n (%), 
TC > 4.5 mmol/l
907 (50.2) 966 (53.0) 911 (60.8) 1 007 (59.1) 959 (62.7) 959 (62.2) < 0.0001
Previous myocardial 
infarction, n (%)
422 (23.3) 400 (22.0) 305 (20.3) 337 (19.8) 273 (17.8) 243 (15.8) < 0.0001
Previous stroke, n (%) 126 (6.9) 149 (8.2) 113 (7.5) 137 (8.0) 107 (7.0) 88 (5.7) 0.077
Atrial fi brillation, n (%) 222 (12.2) 221 (12.1) 173 (11.5) 209 (12.3) 149 (9.7) 153 (9.9) 0.051
PCI at index hospitalization, n (%) 242 (13.3) 400 (22.0) 506 (33.8) 542 (31.8) 890 (58.2) 1038 (67.3) < 0.0001
Coronary angiography at 
index hospitalization, n (%)
– – 523 (34.9) 582 (34.2) 948 (62.0) 1076 (69.8) < 0.0001
Aspirin, n (%) 1 703 (93.8) 1 712 (93.9) 1 412 (94.2) 1 593 (93.5) 1 465 (95.8) 1 475 (95.7) 0.013
Thienopyridines, n (%) 548 (30.2) 1 153 (63.2) 1 232 (82.2) 1 398 (82.1) 1 380 (90.2) 1 458 (94.6) < 0.0001
ACE-inhibitors, n (%) 1 222 (67.3) 1 269 (69.6) 997 (66.5) 1 130 (66.4) 1 021 (66.7) 962 (62.4) 0.001
Beta-blockers, n (%) 1 523 (83.9) 1 490 (81.7) 1 276 (85.1) 1 430 (84.0) 1 298 (84.8) 1 272 (82.5) 0.061
Statins, n (%) 1 456 (80.2) 1 566 (85.9) 1 318 (87.9) 1 478 (86.8) 1 374 (89.8) 1 369 (88.8) < 0.0001
GP IIb/IIIa inhibitors, n (%) 195 (10.7) 314 (17.2) 452 (30.2) 478 (28.1) 665 (43.5) 721 (46.8) < 0.0001
Fig. 1 – Annual incidence of STEMI and NSTE-ACS according to ACS
registry calculated per million inhabitants of Latvia.
* According to Central Statistical Bureau Database of Latvia re-
sident population at the beginning of the following years were: 
2,306,434 in 2005, 2,294,590 in 2006, 2,281,305 in 2007, 2,270,894 in 
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Absolute numbers of transferred patients from commu-
nity hospitals to PCI centers increased over years (Fig. 3). 
Discussion
The main challenges in last twenty years have been the 
reduction of incidence of cardiovascular disease and the 
reduction of cardiovascular mortality. For this purpose 
continuous education of cardiologists, emergency care 
specialists and general practitioners has been implemen-
ted. Multiple, regular educational seminars and congres-
ses were held during this time period across the country, 
and local guidelines on acute coronary care were develo-
ped in 2006 and updated in 2011. Local recommendations 
on stable coronary disease and coronary prevention were 
developed and implemented in real life practice. Besides 
availability of coronary care services such as diagnostic 
coronary angiography, coronary intervention, exercise 
test and non-invasive cardiac imaging have remarkably 
improved. For example, annual increase of diagnostic 
coronary angiograms have risen from 2 258 in 2005 to 
5 643 in 2010 per million population with respective in-
crease in PCI from 1 169 to 2 859 per million population 
in Latvia. Increase in coronary interventions was achieved 
with education of new interventional cardiologists, the 
opening of new catheterization laboratories and inter-
ventional centers. Since 2003 two university hospitals pro-
vide interventional coronary care in Riga. Two additional 
interventional centers in 2007 were opened in two other 
cities (Daugavpils and Liepaja) both situated more than 
200 kilometers from the capital Riga. 
Evaluation of intra-hospital acute coronary care con-
fi rmed better adherence to evidence-based guidelines. 
Not only more frequent administration of recommended 
drugs but also more common use of diagnostic corona-
ry angiograms followed by PCI was observed. Increase in 
the use of interventional strategy in the management of 
tal number of patients hospitalized with NSTE-ACS dec-
reased almost two fold based on registry data. Early in-
terventional strategy and better adherence to guidelines 
recommended therapies improved in NSTE-ACS patients 
over years (Table 1). Reduction in intra-hospital mortality 
was observed in year 2010 in NSTE-ACS patients (Table 1).
The use of P-PCI in Latvia signifi cantly increased from 
7.9% in 2005 to 57.0% in 2010 along with use of anti-
platelet therapy (Tables 2 and 3). The most prominent 
increase was observed in use of clopidogrel – 30.2% in 
2005 compared with 94.6% in 2010. Supplementary with 
increase in PCI rates use of GP IIb/IIIa inhibitors rose from 
10.7% in 2005 to 46.8% in 2010. Proportion of STEMI pa-
tients without any reperfusion decreased from 46.3% in 
year 2005 to 20.8% in 2010 (Fig. 2). However, only sli-
ght decrease of intra-hospital mortality in STEMI patients 
over years was observed. Intra-hospital mortality rates in 
STEMI patients without any reperfusion remained very 
high (Table 4).
Table 3 – Characteristics of STEMI patients hospitalized within 12 hours after symptom onset.
2005 2006 2007 2008 2009 2010 p-value
Number of patients, n 1 290 1 365 1 082 1 236 1 112 1 132
Cardiogenic shock, n (%) 117 (9.1) 153 (11.2) 98 (9.1) 121 (9.8) 166 (14.9) 131 (11.6) < 0.0001
Intra-hospital death, n (%) 216 (16.7) 222 (16.3) 143 (13.2) 189 (15.3) 165 (14.8) 161 (14.2) 0.135
Age ± SD, years 67.20 ± 11.78 66.61 ± 12.58 65.79 ± 12.36 67.08 ± 12.19 65.89 ± 13.47 66.20 ± 12.60 0.018
Reperfusion
  Fibrinolysis, n (%) 591 (45.8) 541 (39.7) 396 (36.6) 489 (39.6) 302 (27.2) 250 (27.2) < 0.0001
  Primary PCI, n (%) 102 (7.9) 215 (15.8) 322 (29.8) 339 (27.4) 522 (46.9) 645 (57.0) < 0.0001
  Without reperfusion, n (%) 597 (46.3) 605 (44.3) 364 (33.6) 408 (33.0) 288 (25.9) 236 (20.8) < 0.0001
PCI at index hospitalization, n (%) 184 (14.3) 313 (23.0) 387 (35.8) 420 (34.0) 650 (58.5) 738 (65.2) < 0.0001
Aspirin, n (%) 1 222 (94.7) 1 280 (93.8) 1 029 (95.1) 1 170 (94.7) 1 061 (95.4) 1 077 (95.1) 0.514
Thienopyridines, n (%) 415 (32.2) 892 (65.3) 905 (83.6) 1 035 (83.7) 1 011 (90.9) 1 064 (94.0) < 0.0001
ACE-inhibitors, n (%) 867 (67.2) 939 (68.8) 728 (67.3) 827 (66.9) 729 (65.6) 684 (60.4) < 0.0001
Beta-blockers, n (%) 1 092 (84.7) 1 116 (81.8) 928 (85.8) 1 050 (85.0) 934 (84.0) 920 (81.3) 0.013
Statins, n (%) 1 048 (81.2) 1 173 (86.0) 957 (88.4) 1 083 (87.6) 1 002 (90.1) 998 (88.2) < 0.0001
GP IIb/IIIa inhibitors, n (%) 144 (11.2) 253 (18.5) 355 (32.8) 372 (30.1) 491 (44.2) 568 (50.2) < 0.0001
Fig. 2 – Reperfusion in STEMI patients hospitalized within 12 hours 
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both NSTE-ACS and STEMI was the result of not only phy-
sician education and availability of interventional centers, 
but also restructuring and centralization of EMS in Latvia.
Admission to higher-volume hospitals was associated 
with a reduction in mortality for acute myocardial infarc-
tion according to literature [17], thus number of small 
capacity community hospitals was restructured to serve 
as ambulatory clinics and total number of hospitals pro-
viding acute coronary care was reduced from 35 in year 
2005 to 18 in year 2010. Reduction of low capacity hos-
pitals in acute coronary care network provides possibility 
for ACS patients to be hospitalized to higher-volume cen-
ters, thus expecting better quality of care and prognosis. 
Majority of patients with ACS arrive at the hospital via 
EMS ambulance in Latvia, thus EMS plays a crucial role in 
the distribution of ACS patients among hospitals. EMS was 
restructured and served as a centralized system ensuring 
hospitalization of ACS patients to tertiary centers only since 
2009–2010. STEMI network algorithms were adapted from 
European Society of Cardiology recommendations and ad-
justed for local situation, published in local guidelines and 
implemented in real life practice [4–6]. Thus, more STEMI 
patients were routed directly to interventional centers or 
transferred on the next day after FL if more than 2-hour 
delay from the fi rst medical contact to balloon was expec-
ted. As a result signifi cant increase in use of P-PCI from 7.9% 
in 2005 to 57.0% in 2010 and decrease in STEMI patients 
without any reperfusion was observed (Table 3, Fig. 2). 
P-PCI is preferable and it is the leading reperfusi-
on strategy for STEMI in most European countries [18], 
however, in the “real world” choice of a management 
strategy is often governed by the facilities available in the 
hospital where patients initially present. Only four hos-
pitals in Latvia (two hospitals in Riga) have PCI facilities 
and 24-hour/7-day interventional access is available only 
in Riga (since 2007 one hospital and since February 2010 
two hospitals).  
Positive associations between interventional strategy 
and improved outcomes in patients with ACS argue for 
the routing of those patients from community hospitals 
to hospitals with access to catheterization laboratory 
[18–24]. Partly, problems were settled with better orga-
nization of networks among the EMS and P-PCI hospitals. 
This resulted in signifi cant increase in absolute numbers 
of transferred patients from community hospitals to PCI 
centers over years (Fig. 2). Those patients were routed to 
Latvian Centre of Cardiology mainly for coronary inter-
vention. 74.5% (n = 190) from transferred NSTE-ACS and 
90.7% (n = 233) from transferred STEMI patients under-
went interventional treatment at index hospitalization 
in year 2010. Coronary angiography was performed in 
91.0% (n = 232) transferred NSTE-ACS and in 95.7% (n = 
246) transferred STEMI patients in 2010. 
Despite better adherence to guidelines recommended 
therapies only slight decrease in intra-hospital mortality 
was achieved. Very high intra-hospital death rates were 
observed in patient subgroup without any reperfusion 
(Table 4) contributing to high total intra-hospital morta-
lity rates in STEMI patients. STEMI patients in cardioge-
nic shock had high in-hospital mortality, especially those 
without reperfusion ranging from 72 to 85% in this sub-
set. Reperfused patients in cardiogenic shock had almost 
halved in-hospital morality rates compared to patients 
without reperfusion therapy. Patients in cardiogenic 
shock in P-PCI subgroup had worsened outcomes com-
pared to fi brinolysis subgroup evaluating mortality rate 
alone. However, rates of P-PCI especially in last years have 
increased. P-PCI was widely applied in critically ill, resus-
citated cardiogenic shock patients, and even in those 
with serious accompanying diseases possibly regarded as 
contraindication for FL.
In-hospital mortality rates in STEMI patients undergoing 
P-PCI in respect to percent from treated patients increased 
over years. However, in time period from 2005 to 2007 
P-PCI was performed in selected patients, but since 2008 
in Latvian Centre of Cardiology and since 2009 in Riga 
Table 4 – In-hospital mortality in STEMI patients hospitalized within 12 hours after symptom onset.
Year










2005, % (n) 1.2% (1) 10.3% (57) 17.0% (89) 17.6% (3) 41.7% (15) 81.0% (51) 4.0% (4) 12.2% (72) 23.9% (140)
2006, % (n) 0.5% (1) 6.6% (33) 17.2% (89) 33.3% (7) 55.6% (25) 75.9% (66) 3.7% (8) 10.7% (58) 25.6% (155)
2007, % (n) 0.3% (1) 9.3% (35) 16.5% (53) 50.0% (18) 26.3% (5) 72.1% (31) 5.9% (19) 10.1% (40) 23.1% (84)
2008, % (n) 0.3% (1) 10.9% (50) 18.6% (66) 47.4% (18) 44.8% (13) 75.9% (41) 5.6% (19) 12.9% (63) 26.2% (107)
2009, % (n) 2.6% (12) 9.4% (24) 13.6% (32) 54.5% (36) 34.0% (16) 84.9% (45) 9.2% (48) 13.2% (40) 26.7% (77)
2010, % (n) 3.1% (18) 11.9% (26) 19.3% (38) 58.3% (35) 43.8% (14) 76.9% (30) 8.2% (53) 16.0% (40) 28.8% (68)
Fig. 3 – Absolute number of transferred patients from community 
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Eastern Clinical University Hospital P-PCI policy for all-
-comers was initiated. Thus, critically ill patients as well 
as aging patients and patients with contraindications for 
other treatment options received P-PCI, which led to relati-
vely higher in-hospital mortality rates in respect to percent 
from treated patients in this subset. Nonetheless, the total 
in-hospital mortality in STEMI patients (Tables 2 and 3) was 
decreasing over years, thus incremental benefi t of more 
aggressive reperfusion in combination with better use of 
drug therapy could serve as explanation.
A higher proportion of STEMI patients were hospita-
lized in cardiogenic shock (8.6% in 2005 versus 10.2% 
in 2010) and higher proportion of patients in age group 
above 80 years (15.7% in 2005 vs. 18.4% in 2010 from all 
ACS patients), subgroup of patients with worsened pro-
gnosis. This registry is limited only with in-hospital data, 
which in terms of mortality is not the best refl ection of 
quality of care, while guidelines based management, 
P-PCI in STEMI and early interventional strategy in 
NSTE-ACS are believed to reduce serious adverse cardiac 
events including mortality in longer term [6,7,10–14].
In NSTE-ACS patients intra-hospital death rate de-
creased in 2010 compared with 2006–2009, possibly re-
fl ecting better adherence to guidelines recommended 
therapy and intensifi ed patient transfer from community 
hospitals to interventional centers. 
Emergency care specialists, cardiologists, and general 
practitioners are being continuously educated; however, 
acceptable reperfusion rates in STEMI patients were not 
achieved. Insuffi cient amount of trained and experienced 
interventional cardiologists outside capital city is the main 
barrier for wider P-PCI implementation across the country. 
Until now some physicians and EMS specialists have con-
servative attitude towards early interventional strategy in 
STEMI as well as in NSTE-ACS. Thus, the development of ACS 
teams at community hospitals able to identify STEMI pa-
tients accurately as well as high and immediate risk 
NSTE-ACS eligible for P-PCI or early interventional 
treatment, correctly administer preferred initial medicati-
ons, and rapidly transfer patients directly to the speciali-
zed center is still needed.
Conclusions
Annual incidence of ACS, especially NSTE-ACS as asse-
ssed by acute coronary syndrome registry decreased over 
years. Better adherence to guidelines recommended the-
rapy and more often use of interventional strategy in 
analyzed time period from year to year was observed. 
A nationwide P-PCI strategy for STEMI was introduced 
in the previous years and subsequently the rate of P-PCI 
increased seven-fold since 2005. Nevertheless, still sig-
nifi cant number of STEMI patients did not receive any 
reperfusion therapy resulting in high mortality rates in 
this subgroup. In NSTE-ACS intra-hospital death rate de-
creased and early interventional strategy increased from 
year to year in analyzed time period.
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